Novel America Invents Act (AIA) adversarial proceedings at the United States Patent and Trademark Office are increasingly popular avenues of attack for challenging the validity of pharmaceutical patents. During this one hour program, we will examine key statistics with respect to the filing, institution and outcome of these proceedings, and discuss lessons learned to date from final written decisions.
Webinar: Current Status of Pharmaceutical Patents in Post Grant Proceedings
21 June 201612:30 PM (EST)
21 June 2016
12:30 PM (EST)